Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
To move Epitalon from experimental to evidence-based, several developments are essential: Randomized, double-blind, placebo-controlled clinical trials, ideally targeting specific endpoints (sleep, immune aging, telomere attrition) Toxicology and long-term safety studies, including exploration of stereoisomer effects and off-target consequences Validated delivery systems (e.g., dendrimer-conjugates, transdermal patches) that make real-world use feasible Pharmacodynamic biomarkers, to identify responders and track efficacy objectively over time Epitalon is not snake oil, but its also not a magic bullet
Frequent monitoring and prompt treatment adjustments may be the key to preventing overcorrection
Parsons CL, Housley T, Schmidt JD et al: Treatment of interstitial cystitis with intravesical heparin
MOTS-c mitochondrial-derived peptide cross-referenced in metabolic-rate research
US$ 22.79
US$ 27.50
US$ 20.37
US$ 21.50
